Start a live chat
1-800-870-4800
Glycation and collagen —
what happens when sugar
meets the triple helix.
Glucose in the bloodstream interacts non-enzymatically with the body's long-lived proteins. Collagen is the longest-lived structural protein the body produces. Over time, the slow chemical reaction between sugar molecules and the amino acid residues of collagen produces a family of compounds the literature calls advanced glycation end products — AGEs. The biology is well-documented, and the relationship is one of the more thoroughly studied chemistries in connective-tissue research.
I
Glycation as biological chemistry —
a non-enzymatic reaction running slowly across time.
Glycation is a non-enzymatic chemical reaction between a reducing sugar (most prominently glucose) and the amino group of a protein. Unlike most reactions in human biology, it does not require an enzyme — it proceeds spontaneously whenever glucose and a suitable amino group are in the same molecular neighbourhood for long enough. The initial product is reversible (a Schiff base, then an Amadori product), but over time and under sustained exposure, these early products undergo further chemical rearrangement into a family of stable compounds the literature calls advanced glycation end products, or AGEs. The general chemistry is, in fact, the same Maillard reaction that occurs when food is browned during cooking — the difference is that in the body, the reaction runs at body temperature, on physiological substrates, slowly across years.
What makes collagen particularly susceptible to glycation is its longevity. As the article on collagen turnover in this cluster describes, collagen in dense connective tissues — bone, tendon, cartilage — turns over on a timescale of years to decades. A protein that remains in place for that long has, by simple chemistry, far more opportunity to undergo non-enzymatic modification than a protein that turns over in hours or days. The slow turnover that gives collagen its mechanical durability is also what gives glycation enough time to accumulate. The slow trajectory of collagen across the lifespan, described in the previous article of this cluster, includes the slow accumulation of AGEs as one of its documented dimensions.
The connective-tissue biology literature has documented the formation of specific AGE compounds in human collagen with some precision. Compounds such as carboxymethyl-lysine and pentosidine are formed in the slow chemical reactions between glucose-derived intermediates and lysine and other residues on the collagen chain. Their concentrations in tissue samples have been used in research as biomarkers of slow connective-tissue modification across the lifespan. The biology of AGE formation, accumulation, and tissue-specific distribution continues to be an active area of research, and the picture this article describes reflects the current state of understanding rather than a closed account.
A protein that lasts decades
has decades of opportunity
to undergo slow chemistry.
Glycation is, in this sense,
a consequence of collagen's own longevity.
The glycation process — four stages
From glucose encounter
to advanced glycation end product.
The glycation reaction proceeds through a defined sequence of slow chemical steps. The cards below summarise the stages documented in connective-tissue biochemistry, from the initial reversible glucose attachment to the formation of the stable advanced glycation compounds that the literature has characterised in collagen across the lifespan.
Stage 01
Schiff base
Reversible attachment
Glucose (or another reducing sugar) reacts non-enzymatically with the amino group of a lysine, arginine, or N-terminal amine on the collagen chain, forming a Schiff base — a reversible chemical adduct. At this stage, the modification can spontaneously dissociate back to glucose and unmodified protein. The Schiff base stage is the initial step in every subsequent glycation product.
Stage 02
Amadori product
Rearranged but reversible
Over hours to days, the Schiff base rearranges chemically into a more stable form called an Amadori product. Like the Schiff base, the Amadori product is still potentially reversible, but it is sufficiently stable that it accumulates in tissue when sustained glucose exposure is present. Glycated haemoglobin (HbA1c), measured in laboratory tests, is an Amadori-stage modification of a different protein — but the same chemistry that occurs on collagen.
Stage 03
Intermediate AGEs
Slow conversion
Over weeks to months, Amadori products undergo further chemical conversion — through several intermediate stages involving rearrangement, dehydration, and oxidative chemistry — toward stable end products. This intermediate phase is where the chemistry becomes essentially irreversible and where the long-term accumulation of glycation modifications in collagen begins to be established.
Stage 04
Mature AGEs
Irreversible end products
The final stage produces stable advanced glycation end products — including compounds like carboxymethyl-lysine, pentosidine, and glucosepane — that are chemically stable and accumulate across decades in long-lived tissue proteins like collagen. These mature AGEs are documented in research as cumulative biomarkers of slow non-enzymatic modification across the lifespan.
II
What the literature documents about AGEs in collagen —
the long-running record of a slow chemical process.
The accumulation of advanced glycation end products in collagen across the lifespan has been documented in some detail in the connective-tissue research literature. Stable AGE compounds — pentosidine, glucosepane, and others — have been measured in tissue samples and their concentrations described across various age ranges and tissue types. The general pattern the literature describes is one of slow accumulation across the adult lifespan, with the long-turnover tissues (cartilage, the deeper dermis, bone matrix) accumulating substantially more than tissues with faster turnover. The pattern is consistent with the underlying chemistry: a slow reaction running on a long-lived substrate produces, over time, a large amount of slowly accumulated product.
The biological consequences of AGE accumulation in collagen are an active research area in the connective-tissue literature, and the picture continues to be refined. AGEs in collagen are documented as contributing to the slow changes in matrix mechanical properties described in the previous article of this cluster, and as one of the dimensions of collagen modification that accumulates alongside the mature crosslinks described in the crosslinking article. The literature describes AGEs as one of several layered processes that contribute to the overall trajectory of collagen across decades; it does not, in general, attribute the trajectory to AGEs alone.
What follows from this picture, for the framing of dietary substrate supply, is the same continuity argument that runs through the rest of this cluster. The body's collagen-producing cells continuously synthesise new collagen, the body's MMP enzymes continuously break some of it down, and the collagen present in any tissue at any moment is the slow-running balance of those processes — modified by the accumulated chemistry of crosslinking, glycation, and other slow non-enzymatic processes. Dietary input to the substrate side runs continuously alongside. The Codeage multi-collagen line — Codeage's Multi Collagen Protein Powder and the rest of the formulations — supplies amino acid substrate to that ongoing biology; the broader nutritional and dietary context provides the rest.
The body's longest-lived proteins
accumulate the longest record of chemistry.
Glycation is one chapter of that record.
The crosslinks are another.
Glycation and collagen in numbers
What the literature describes,
at three measurable scales.
Decades
The timescale across which advanced glycation end products accumulate in long-lived collagen pools — running on the slow tempo of the underlying chemistry
AGE accumulation in collagen runs on the same slow timescale as collagen turnover itself. Tissues with slow turnover — articular cartilage, tendon, the deepest dermis — accumulate substantially more AGEs than tissues with faster turnover, simply because the substrate (the collagen molecule) is in place long enough for the slow chemistry to occur. The decades-long timescale is one of the defining features of the process.
Non-enzymatic
The chemical character of the glycation reaction — proceeding spontaneously rather than through enzymatic action
Unlike most reactions in human biochemistry, glycation does not require an enzyme. It proceeds whenever glucose and a suitable amino group are in chemical contact for long enough. This non-enzymatic character is one of the reasons glycation is not amenable to the same kinds of regulatory control the body uses for enzyme-mediated reactions, and is one of the underlying reasons it accumulates slowly but continuously across the lifespan.
Documented
The status of glycation in the research literature — among the more thoroughly characterised slow chemical processes in connective-tissue biology
AGE formation and accumulation have been studied in considerable detail across several decades of connective-tissue research. Specific AGE compounds (pentosidine, carboxymethyl-lysine, glucosepane) have been characterised chemically and measured in tissue samples. The biology of AGE formation, distribution, and the cellular response to it is one of the well-established areas of connective-tissue research, even as specific details continue to be refined.
III
What this means for substrate supply —
biology described, no claim implied.
This article describes a documented chemical process in connective-tissue biology. It does not claim that any dietary input — including multi-collagen formulations — has been demonstrated to alter the rate or accumulation of glycation, the formation of advanced glycation end products, or any specific tissue-level consequence of either. The connective-tissue biology literature continues to investigate the dietary, lifestyle, and metabolic factors that affect glycation rates, and the relationship between those factors and tissue-level outcomes remains an open research area.
What this article does describe is the underlying chemistry of a slow process that runs in long-lived collagen across the lifespan, and the framing within which collagen-related dietary substrate sits. The body's collagen-producing cells continuously synthesise new collagen using amino acid substrate from dietary protein. Collagen-rich dietary sources like Codeage's Multi Collagen Protein Powder — five collagen types from four sources — supply the characteristic amino acid profile that the body's collagen production uses. The substrate is supplied continuously alongside the continuous biology, in the same framing this entire cluster has held.
As with the rest of this cluster, the picture described in this article reflects the current state of the connective-tissue research literature rather than a closed account. The studies referenced were conducted independently and did not involve any specific Codeage product — what is described here is the documented chemistry of glycation in collagen, not a claim about the effect of any formulation on it. The next article in this cluster turns from the chemistry of slow modification to the mechanical properties of collagen as a structural protein — the tensile strength, elasticity, and engineering of the fibril architecture. For the wider context, The Longevity Code situates this dimension within the four-pillar daily framework of the Codeage system.
Codeage · Structural Integrity · Pillar 02
A multi-collagen architecture,
built around the substrate.
Three formulations from the Codeage collagen line — each supplying the multi-type collagen amino acid profile in a different format.
Multi Collagen Protein Powder
Five collagen types — I, II, III, V, X — drawn from four sources: grass-fed bovine, wild-caught marine, chicken cartilage, and eggshell membrane. Unflavoured. Mixes into water, coffee, or smoothies. The flagship of the Codeage collagen architecture.
View Product →Wild Caught Marine Collagen Peptides
Wild-caught marine collagen peptides — Type I in its marine molecular form, hydrolysed for solubility. A single-source collagen complement to the multi-collagen line for those building a layered architecture.
View Product →Multi Collagen Peptides Chocolate
Multi-collagen peptides in a hydrolysed chocolate-flavoured profile. Five collagen types from four sources in a peptide format intended to mix with milk, plant milk, or as part of a smoothie or coffee.
View Product →Previously in the Multi-Collagen series
Vitamin C and collagen — the cofactor relationship at the heart of the triple helix.
Codeage · The Longevity Code
A system built for
the structural long view.
The Longevity Code is a four-pillar daily system — every formulation mapped to a specific dimension of how the body sustains itself across time. Multi-collagen is the structural protein of Pillar 02.
Explore The Longevity Code →
